# Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia

> **NCT03422640** · PHASE4 · UNKNOWN · sponsor: **Bellevue Dermatology** · enrollment: 20 (estimated)

## Conditions studied

- Frontal Fibrosing Alopecia

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT03422640
- **Lead sponsor:** Bellevue Dermatology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-12
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03422640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03422640, "Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03422640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*